{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T22:17:53Z","timestamp":1757542673622},"publisher-location":"Vienna","reference-count":99,"publisher":"Springer Vienna","isbn-type":[{"type":"print","value":"9783211330784"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1007\/978-3-211-33079-1_20","type":"book-chapter","created":{"date-parts":[[2007,5,26]],"date-time":"2007-05-26T21:56:12Z","timestamp":1180216572000},"page":"145-154","source":"Crossref","is-referenced-by-count":2,"title":["Intrathecal baclofen in current neuromodulatory practice: established indications and emerging applications"],"prefix":"10.1007","author":[{"given":"I. G.","family":"Panourias","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Themistocleous","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damianos E.","family":"Sakas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"20_CR1","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1001\/jama.265.11.1418","volume":"265","author":"A.L. Albright","year":"1991","unstructured":"Albright AL, Cervi A, Singletary J (1991) Intrathecal baclofen for spasticity in cerebral palsy. JAMA 265: 1418\u20131422","journal-title":"JAMA"},{"key":"20_CR2","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1001\/jama.270.20.2475","volume":"270","author":"L.A. Albright","year":"1993","unstructured":"Albright LA, Barron WB, Fasick MP, Polinko P, Janosky J (1993) Continuous intrathecal baclofen infusion for infusion for spasticity of cerebral origin. JAMA 270: 2475\u20132478","journal-title":"JAMA"},{"key":"20_CR3","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1017\/S0012162201001190","volume":"43","author":"A.L. Albright","year":"2001","unstructured":"Albright AL, Barry MJ, Shafron DH, Ferson SS (2001) Intrathecal baclofen for generalized dystonia. Dev Med Child Neurol 43: 652\u2013657","journal-title":"Dev Med Child Neurol"},{"key":"20_CR4","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3171\/jns.2003.98.2.0291","volume":"98","author":"A.L. Albright","year":"2003","unstructured":"Albright AL, Gilmartin R, Swift D, Krach LE, Ivanhoe CB, McLaughin JF (2003) Long-term intrathecal baclofen therapy for severe spasticity of cerebral origin. J Neurosurg 98: 291\u2013295","journal-title":"J Neurosurg"},{"key":"20_CR5","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1007\/BF00164791","volume":"348","author":"M. Amano","year":"1993","unstructured":"Amano M, Kubo T (1993) Involvement of both GABA A and GABA B receptors in tonic inhibitory control of blood pressure at the rostral ventrolateral medulla of the rat. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 348: 146\u2013153","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"20_CR6","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3171\/jns.1997.87.3.0409","volume":"87","author":"R.W. Armstrong","year":"1997","unstructured":"Armstrong RW, Steinbok P, Cochrane DD, Kube SD, Fife SE, Farrel K (1997) Intrathecally administered baclofen for treatment of children with spasticity of cerebral origin. J Neurosurg 87: 409\u2013414","journal-title":"J Neurosurg"},{"key":"20_CR7","first-page":"540","volume":"192","author":"B. Ashworth","year":"1964","unstructured":"Ashworth B (1964) Preliminary trial of carisoprodol in multiple sclerosis. Practicioner 192: 540\u2013542","journal-title":"Practicioner"},{"key":"20_CR8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0003-9993(96)90217-8","volume":"77","author":"P. Azouvi","year":"1996","unstructured":"Azouvi P, Mane M, Thiebaut JB, Denys P, Remy-Neris O, Bussel B (1996) Intrathecal baclofen administration for control of severe spinal spasticity: functional improvement and long-term follow-up. Arch Phys Med Rehabil 77: 35\u201339","journal-title":"Arch Phys Med Rehabil"},{"key":"20_CR9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/jnnp.67.1.39","volume":"67","author":"I.J. Baguley","year":"1999","unstructured":"Baguley IJ, Nicholls JL, Felmingham KL, Crooks J, Gurka JA, Wade LD (1999) Dysautonomia after traumatic brain injury: a forgotten syndrome? J Neurol Neurosurg Psychiatry 67: 39\u201343","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Suppl 1","key":"20_CR10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/ageing\/30.suppl_1.13","volume":"30","author":"M.P. Barnes","year":"2001","unstructured":"Barnes MP (2001) Medical management of spasticity in stroke. Age Ageing 30Suppl 1: 13\u201316","journal-title":"Age Ageing"},{"key":"20_CR11","first-page":"77","volume":"12","author":"M.J. Barry","year":"2000","unstructured":"Barry MJ, VanSwearingen JM, Albright AL (2000) Intrathecal baclofen therapy and the role of the physical therapist. Ped Phy Ther 12: 77\u201386","journal-title":"Ped Phy Ther"},{"key":"20_CR12","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s004150050067","volume":"244","author":"R. Becker","year":"1997","unstructured":"Becker R, Alberti O, Bauer BL (1997) Continuous intrathecal baclofen infusion in severe spasticity after traumatic or hypoxic brain injury. J Neurol 244: 160\u2013166","journal-title":"J Neurol"},{"key":"20_CR13","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/jnnp.66.1.114","volume":"66","author":"R. Becker","year":"1999","unstructured":"Becker R, Sure U, Petermeyer M, Bertalanffy H (1999) Continuous intrathecal baclofen infusion alleviates autonomic dysfunction in patients with severe supraspinal spasticity. J Neurol Neurosurg Psychiatry 66: 114\u2013125","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"20_CR14","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1054\/jocn.1999.0227","volume":"7","author":"R. Becker","year":"2000","unstructured":"Becker R, Benes L, Sure U, Hellwig D, Bertallanfy H (2000) Intrathecal baclofen alleviates autonomic dysfunction in severe brain injury. J Clin Neurosci 7: 316\u2013319","journal-title":"J Clin Neurosci"},{"key":"20_CR15","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0025-6196(11)63647-1","volume":"73","author":"B.F. Boeve","year":"1998","unstructured":"Boeve BF, Wijdicks EFM, Benarroch EE, Schimdt KD (1998) Paroxysmal sympathetic storms (diencephalic seizures) after severe diffuse axonal head injury. Mayo Clinics Proceedings 73: 148\u2013152","journal-title":"Mayo Clinics Proceedings"},{"key":"20_CR16","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/ptj\/67.2.206","volume":"67","author":"R.W. Bohannon","year":"1987","unstructured":"Bohannon RW, Smith MB (1987) Inter rater reliability of a modified Ashworth Scale of muscle spasticity. Phys Ther 67: 206\u2013207","journal-title":"Phys Ther"},{"key":"20_CR17","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.clineuro.2004.09.007","volume":"107","author":"E. Boviatsis","year":"2005","unstructured":"Boviatsis E, Kouyialis AT, Korfias S, Sakas DE (2005) Functional outcome of intrathecal baclofen administration for severe spasticity. Clin Neurol Neurosurg 107: 289\u2013295","journal-title":"Clin Neurol Neurosurg"},{"key":"20_CR18","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1146\/annurev.pa.33.040193.000545","volume":"33","author":"N.G. Bowery","year":"1993","unstructured":"Bowery NG (1993) GABA B receptor pharmacology. Annu Rev Pharmacol Toxicol 33: 109\u2013147","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"20_CR19","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1124\/pr.54.2.247","volume":"54","author":"N.G. Bowery","year":"2002","unstructured":"Bowery NG, Bettler B, Froestl W, Gallagher JP, Marshall F, Raiteri M, Bonner TI, Enna SJ (2002) International Union of Pharmacology. XXXIII. Mammalian gamma-aminobutyric acid (B) receptors: structure and function. Pharmacol Rev 54: 247\u2013264","journal-title":"Pharmacol Rev"},{"key":"20_CR20","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/sj.sc.3101178","volume":"39","author":"A.S. Burns","year":"2001","unstructured":"Burns AS, Meythaler J (2001) Intrathecal baclofren in tetraplegia of spinal origin: efficacy for upper extremity hypertonia. Spinal Cord 39: 413\u2013419","journal-title":"Spinal Cord"},{"key":"20_CR21","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/ptj\/75.5.352","volume":"75","author":"S.K. Campbell","year":"1995","unstructured":"Campbell SK, Almeida GL, Penn RD, Corcos DM (1995) The effects of intrathecally administered baclofen on function in patients with spasticity. Phys Ther 75: 352\u2013362","journal-title":"Phys Ther"},{"key":"20_CR22","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1177\/000841740407100406","volume":"71","author":"A. Carswell","year":"2004","unstructured":"Carswell A, McColl MA, Baptiste S, Law M, Polatajko H, Pollock N (2004) The Canadian occupational performance measure: a research and clinical literature review. Can J Occup Ther 71: 210\u2013222","journal-title":"Can J Occup Ther"},{"key":"20_CR23","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1053\/apmr.2002.32820","volume":"83","author":"R.J. Coffrey","year":"2002","unstructured":"Coffrey RJ, Edgar TS, Francisco GE, Graziani V, Meythaler JM, Ridgely PM, Sadiq SA, Turner MS (2002) Abrupt withdrawal from intrathecal baclofen: recognition and management of a potentially life-threatening syndrome. Arch Phys Med Rehabil 83: 735\u2013741","journal-title":"Arch Phys Med Rehabil"},{"key":"20_CR24","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1080\/02699050110065277","volume":"15","author":"E. Cuny","year":"2001","unstructured":"Cuny E, Richrer E, Castel JP (2001) Dysautonomia syndrome in the acute recovery phase after traumatic brain injury: relief with intrathecal baclofen therapy. Brain Inj 15: 917\u2013925","journal-title":"Brain Inj"},{"key":"20_CR25","unstructured":"Dones I (2006) Intrathecal baclofen for the treatment of spasticity: selection criteria, management and efficacy in the wheel-chaired and bedridden versus the mobile patients. Acta Neurochir Suppl (in press)"},{"key":"20_CR26","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.apmr.2004.11.001","volume":"86","author":"D.D. Dykstra","year":"2005","unstructured":"Dykstra DD, Mendez A, Chappuis D, Baxter T, DesLauriers L, Stuckey M (2005) Treatment of cervical dystonia and focal hand dystonia by high cervical continuously infused intrathecal baclofen: a report of two cases. Arch Phys Med Rehabil 86: 830\u2013833","journal-title":"Arch Phys Med Rehabil"},{"key":"20_CR27","unstructured":"Dykstra D, Stuckey M, DesLauries L, Chappuis D, Krach L (2006) Intrathecal baclofen in the treatment of spasticity: indications, selection criteria, management and outcome in the adult versus the pediatric population. Acta Neurochir Suppl (in press)"},{"key":"20_CR28","first-page":"1","volume":"50","author":"S. Fann","year":"1988","unstructured":"Fann S (1988) Concept and classification of dystonia. Adv Neurol 50: 1\u20138","journal-title":"Adv Neurol"},{"key":"20_CR29","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/0306-4522(78)90016-7","volume":"3","author":"S. Fox","year":"1978","unstructured":"Fox S, Krnjevic K, Morris ME, et al (1978) Action of baclofen on mammalian synaptic transmission. Neuroscience 3: 495\u2013515","journal-title":"Neuroscience"},{"key":"20_CR30","first-page":"2108","volume":"32","author":"G.E. Francisco","year":"2001","unstructured":"Francisco GE (2001) Can intrathecal baclofen therapy unleash functional recovery after stroke? Stroke 32: 2108\u20132109","journal-title":"Stroke"},{"key":"20_CR31","first-page":"75","volume":"79","author":"S. Gatscher","year":"2002","unstructured":"Gatscher S, Becker R, Uhle E, Bertalanffy H (2002) Combined intrathecal baclofen and morphine infusion for the treatment of spasticity related pain and central deafferentation pain. Acta Neurochir Suppl 79: 75\u201376","journal-title":"Acta Neurochir Suppl"},{"key":"20_CR32","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.3171\/jns.1998.88.6.1009","volume":"88","author":"P.C. Gerszten","year":"1998","unstructured":"Gerszten PC, Albright AL, Johnstone GF (1998) Intrathecal baclofen infusion and subsequent orthopedic surgery in patients with spastic cerebral palsy. J Neurosurg 88: 1009\u20131013","journal-title":"J Neurosurg"},{"key":"20_CR33","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/01376517-199802000-00006","volume":"30","author":"J.M. Gianino","year":"1998","unstructured":"Gianino JM, York MM, Paice JA, Shott S (1998) Quality of life: effect of reduced spasticity from intrathecal baclofen. J Neurosci Nurs 30: 47\u201354","journal-title":"J Neurosci Nurs"},{"key":"20_CR34","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1097\/00006123-199910000-00020","volume":"45","author":"P.A. Grabb","year":"1999","unstructured":"Grabb PA, Guin-Renfroe S, Meythaler JM (1999) Midthoracic catheter tip placement for intrathecal baclofen administration in children with quadriparetic spasticity. Neurosurgery 45: 833\u2013836","journal-title":"Neurosurgery"},{"key":"20_CR35","first-page":"S92","volume":"6","author":"J.M. Grades","year":"1997","unstructured":"Grades JM, Nance P, Elovic E, McGuire J, Simpson DM (1997) Traditional pharmacological treatments for spasticity. Part III: General and regional treatments. Muscle Nerve Suppl 6: S92\u2013S120","journal-title":"Muscle Nerve Suppl"},{"key":"20_CR36","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1016\/j.apmr.2005.05.018","volume":"86","author":"D. Guillaume","year":"2005","unstructured":"Guillaume D, Van Havenbergh A, Vloeberghs M, Vidal J, Roeste G (2005) A clinical study of intrathecal baclofen using a programmable pump for intractable spasticity. Arch Phys Med Rehabil 86: 2165\u20132171","journal-title":"Arch Phys Med Rehabil"},{"key":"20_CR37","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/01202412-200507000-00007","volume":"14","author":"G. Hagglund","year":"2005","unstructured":"Hagglund G, Andersson S, Duppe H, Pedertsen HL, Nordmark E, Westbom L (2005) Prevention of severe contractures might replace multilevel surgery in cerebralpalsy: results of a population-based health care programme and new techniques to reduce spasticity. J Pediatr Orthop B 14: 269\u2013273","journal-title":"J Pediatr Orthop B"},{"key":"20_CR38","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/00002508-199212000-00008","volume":"8","author":"R.M. Herman","year":"1992","unstructured":"Herman RM, D\u2019Luzansky JC, Ippolito R (1992) Intrathecal baclofen suppresses central pain in patients with spinal lesions. Clin J Pain 8: 338\u2013345","journal-title":"Clin J Pain"},{"key":"20_CR39","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.apmr.2004.11.013","volume":"86","author":"T.S. Horn","year":"2005","unstructured":"Horn TS, Yablon SA, Stokic DS (2005) Effect of intrathecal baclofen bolus injection on temporospatial gait characteristics in patients with acquired brain injury. Arch Phys Med Rehabil 86: 1127\u20131133","journal-title":"Arch Phys Med Rehabil"},{"issue":"[Suppl]","key":"20_CR40","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1097\/01.PHM.0000141125.28611.3E","volume":"83","author":"C.B. Ivanhoe","year":"2004","unstructured":"Ivanhoe CB, Reistetter TA (2004). Spasticity: the misunderstood part of the upper motor neuron syndrome. Am J Phys Med Rehabil 83[Suppl]: S3\u2013S9","journal-title":"Am J Phys Med Rehabil"},{"key":"20_CR41","first-page":"482","volume":"220","author":"D.A. Kendal","year":"1982","unstructured":"Kendal DA, Browner M, Emma SJ (1982) Comparison of the antinoceceptive effect of gamma-aminobutyric acid (GABA) agonists: evidence for a cholinergic involvement. J Pharmacol Exp Therap 220: 482\u2013487","journal-title":"J Pharmacol Exp Therap"},{"key":"20_CR42","first-page":"73","volume-title":"Parenteral drug therapy in spasticity and Parkinson\u2019s disease","author":"J.S. Kroin","year":"1991","unstructured":"Kroin JS, Penn RD (1991) Cerebrospinal fluid pharmacokinetics of lumbar intrathecal baclofen. In: Lakke JPWF, Delhaas EM, Rutgers AWE (eds) Parenteral drug therapy in spasticity and Parkinson\u2019s disease. Parthenon Publishing, Canforth UK, pp 73\u201383"},{"key":"20_CR43","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1097\/00006123-199308000-00007","volume":"33","author":"J. Kroin","year":"1993","unstructured":"Kroin J, Ali A, York M, Penn RD (1993) The distribution of medication along the spinal canal after chronic intrathecal administration. Neurosurgery 33: 226\u2013230","journal-title":"Neurosurgery"},{"key":"20_CR44","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/j.1440-1754.2004.00374.x","volume":"40","author":"M. Kyriagis","year":"2004","unstructured":"Kyriagis M, Grattan-Smith P, Scheinberg A, Teo C, Nakaji N, Waugh M (2004) Status dystonicus and Hallervorden-Spatz disease: treatment with intrathecal baclofen and pallidotomy. J Paediatr Child Health 40: 322\u2013325","journal-title":"J Paediatr Child Health"},{"key":"20_CR45","first-page":"485","volume-title":"Spasticity, disordered motor control","author":"J.W. Lance","year":"1980","unstructured":"Lance JW (1980) Symposium Synopsis. In: Feldman RG, Young RR, Kellas WP (eds) Spasticity, disordered motor control. Year Book Medical Publishers, CIBA-GEIGY Corporation, Chicago, pp 485\u2013494"},{"key":"20_CR46","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1177\/000841749005700207","volume":"57","author":"M. Law","year":"1990","unstructured":"Law M, Baptiste S, McColl MA, Opzoomer A, Polatajko H, Pollock N (1990) The Canadian occupational performance measure: an outcome measure for occupational therapy. Can J Occup Ther 57: 82\u201387","journal-title":"Can J Occup Ther"},{"key":"20_CR47","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/0014-2999(79)90102-X","volume":"57","author":"R.A. Levy","year":"1979","unstructured":"Levy RA, Proudfit HK (1979) Analgesia produced by microinjection of balcofen and morphine at brainstem sites. Eur J Pharmacol 57: 43\u201355","journal-title":"Eur J Pharmacol"},{"key":"20_CR48","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.ejpain.2003.11.002","volume":"8","author":"G. Lind","year":"2004","unstructured":"Lind G, Meyerson BA, Winter J, Linderoth B (2004) Intrathecal baclofen as adjuvant therapy to enhance the effect of spinal cord stimulation in neuropathic pain: a pilot study. Eur J Pain 8: 377\u2013383","journal-title":"Eur J Pain"},{"key":"20_CR49","unstructured":"Lind G, Schechtmann G, Winter J, Linderoth B (2006) Drugenhanced spinal stimulation for pain: a new strategy. Acta Neurochir Suppl (in press)"},{"key":"20_CR50","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/0885-3924(96)00152-2","volume":"12","author":"P.G. Loubser","year":"1996","unstructured":"Loubser PG, Akman NM (1996) Effects of intrathecal baclofen on chronic spinal cord injury pain. J Pain Symptom Manage 12: 241\u2013247","journal-title":"J Pain Symptom Manage"},{"key":"20_CR51","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s004150050417","volume":"246","author":"G. Marquardt","year":"1999","unstructured":"Marquardt G, Lorenz R (1999) Intrathecal baclofen for intratable spasticity in amyotrophic lateral sclerosis. J Neurol 246: 619\u2013620","journal-title":"J Neurol"},{"key":"20_CR52","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1136\/jnnp.72.2.275","volume":"72","author":"G. Marquardt","year":"2002","unstructured":"Marquardt G, Seifert V (2002) Use of intrathecal baclofen for treatment of spasticity in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 72: 275\u2013276","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"20_CR53","first-page":"1","volume-title":"Spasticity: etiology, management and the role of botulinum toxin","author":"N.H. Mayer","year":"2002","unstructured":"Mayer NH (2002) Clinicophysiologic concepts of spasticity and motor dysfunction in adults with an upper motor neuron lesion. In: Mayer NH, Simpson DM (eds) Spasticity: etiology, management and the role of botulinum toxin. We Move, New York, pp 1\u201311"},{"key":"20_CR54","unstructured":"Medtronic (The) (2002) ITB Therapy Clinical Reference Guide for Spasticity Management UC19961184cEN NP 2584c, Medtronic, Inc"},{"key":"20_CR55","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/00002060-199212000-00003","volume":"71","author":"J.M. Meythaler","year":"1992","unstructured":"Meythaler JM, Steers WD, Tuel SM, Cross LL, Haworht CS (1992) Continuous intrathecal baclofen in spinal cord spasticity. A prospective study. Am J Phys Med Rehabil 71: 321\u2013327","journal-title":"Am J Phys Med Rehabil"},{"key":"20_CR56","first-page":"794","volume":"73","author":"J.M. Meythaler","year":"1992","unstructured":"Meythaler JM, Steers WD, Tuel SM, Cross LL, Sesco DC, Haworth CS (1992) Intrathecal baclofen in hereditary spastic paraparesis. Arch Phys Med Rehabil 73: 794\u2013797","journal-title":"Arch Phys Med Rehabil"},{"key":"20_CR57","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0003-9993(96)90034-9","volume":"77","author":"J.M. Meythaler","year":"1996","unstructured":"Meythaler JM, Devivo JH, Hadely M (1996) Prospective study on the use sof bolus intrathecal baclofen for spastic hypertonia due to acquired brain injury. Arch Phys Med Rehabil 77: 461\u2013466","journal-title":"Arch Phys Med Rehabil"},{"key":"20_CR58","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0003-9993(99)90301-5","volume":"80","author":"J.M. Meythaler","year":"1999","unstructured":"Meythaler JM, Guin-Renfroe S, Grabb P, Hadley MN (1999) Long-term continuously infused intrathecal baclofen for spastic-dystonic hypertonia in traumatic brain injury: 1-year experience. Arch Phys Med Rehabil 80: 13\u201319","journal-title":"Arch Phys Med Rehabil"},{"key":"20_CR59","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1097\/00002060-199905000-00012","volume":"78","author":"J.M. Meythaler","year":"1999","unstructured":"Meythaler JM, Guin-Renfroe S, Hadley MN (1999) Continuously infused intrathecal baclofen for spastic=dystonic hemiplegia: a preliminary report. Am J Phys Med Rehabil 78: 247\u2013254","journal-title":"Am J Phys Med Rehabil"},{"key":"20_CR60","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1161\/hs0901.095682","volume":"32","author":"J.M. Meythaler","year":"2001","unstructured":"Meythaler JM, Guin-Renfroe S, Brunner RC, Hadley MN (2001) Intrathecal baclofen for spastic hypertonia from stroke. Stroke 32: 2099\u20132109","journal-title":"Stroke"},{"key":"20_CR61","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1053\/apmr.2001.19246","volume":"81","author":"J.M. Meythaler","year":"2001","unstructured":"Meythaler JM, Guin-Renfroe S, Law C, Grabb P, Hadely MN (2001) Continuously infused intrahtecal baclofen over 12 months for spastic hyperTonia in adolescents and adults with cerebral palsy. Arch Phys Med Rehabil 81: 155\u2013161","journal-title":"Arch Phys Med Rehabil"},{"key":"20_CR62","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/S0003-9993(96)90264-6","volume":"77","author":"J.W. Middleton","year":"1996","unstructured":"Middleton JW, Siddell PJ, Walker S, Molloy AR, Rutkowski SB (1996) Intrathecal clonidine and baclofen in the management of spasticity and neuropathic pain following spinal cord injury: a case study. Arch Phys Med Rehabil 77: 824\u2013826","journal-title":"Arch Phys Med Rehabil"},{"key":"20_CR63","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1097\/01.PHM.0000156892.04239.B6","volume":"84","author":"F. Molteni","year":"2005","unstructured":"Molteni F, Carda S, Cazzaniga M, Magoni L, Rossini M, Caimmi M (2005) Instrumental evaluation of gait modifications before and during intrathecal baclofen therapy: a 2-year follow-up case study. Am J Phys Med Rehabil 84: 303\u2013306","journal-title":"Am J Phys Med Rehabil"},{"key":"20_CR64","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1053\/apmr.2002.36068","volume":"83","author":"N.A. Murphy","year":"2002","unstructured":"Murphy NA, Irwin MCN, Hoff C (2002) Intrathecal baclofen therapy in children with cerebral palsy: efficacy and complications. Arch Phys Med Rehabil 83: 1721\u20131725","journal-title":"Arch Phys Med Rehabil"},{"key":"20_CR65","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1136\/jnnp.52.8.933","volume":"52","author":"G. Ochs","year":"1989","unstructured":"Ochs G, Struppler A, Meyerson BA, Linderoth B, Gybels J, Gardner BP, Teddy P, Jamous A, Weinmann P (1989) Intrathecal baclofen for long-term treatment of spasticity: a multicenter study. J Neurol Neurosurg Psychiatry 52: 933\u2013939","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"20_CR66","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1046\/j.1525-1403.2002._2004.x","volume":"5","author":"J.I. Ordia","year":"2002","unstructured":"Ordia JI, Fischer E, Adamski E, Chagnon KG, Spatz EL (2002) Continuous intrathecal baclofen infusion by a programmable pump in 131 consecutive patients with severe spasticity of spinal origin. Neuromodulation 5: 16\u201324","journal-title":"Neuromodulation"},{"key":"20_CR67","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/S0140-6736(84)91487-9","volume":"1","author":"R. Penn","year":"1984","unstructured":"Penn R, Kroin JS (1984) Intrathecal baclofen alleviates spinal cord spasticity [letter]. Lancet 1: 1078","journal-title":"Lancet"},{"key":"20_CR68","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0140-6736(85)90228-4","volume":"2","author":"R. Penn","year":"1985","unstructured":"Penn R, Kroin JS (1985) Continuous intrathecal baclofen for severe spasticity. Lancet 2: 125\u2013127","journal-title":"Lancet"},{"key":"20_CR69","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1056\/NEJM198906083202303","volume":"320","author":"R.E.D. Penn","year":"1989","unstructured":"Penn RED, Savoy SM, Corcos D, Latash M, Gottlieb G, Parke B, Kroin JS (1989) Intrathecal baclofen for severe spinal spasticity. N Engl J Med 320: 1517\u20131521","journal-title":"N Engl J Med"},{"key":"20_CR70","doi-asserted-by":"crossref","unstructured":"Petropoulou K, Panourias IG, Rapidi CA, Sakas DE (2006) The importance of neurorehabilitation to the outcome of neuromodulation in spasticity. Acta Neurochir Suppl (in press)","DOI":"10.1007\/978-3-211-33079-1_33"},{"key":"20_CR71","unstructured":"Petropoulou K, Panourias IG, Rapidi CA, Sakas DE (2006) The phenomenon of spasticity: a pathophysiological and clinical introduction to neuromodulation therapies. Acta Neurochirurgica Suppl (in press)"},{"key":"20_CR72","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/sj.sc.3101647","volume":"42","author":"R. Plassat","year":"2004","unstructured":"Plassat R, Perrouin Verbe B, Menei P, Menegalli D, Mathe JF, Richard I (2004) Treatment of spasticity with intrathecal baclofen administration: long-term follow-up, review of 40 patients. Spinal Cord 42: 686\u2013693","journal-title":"Spinal Cord"},{"issue":"10","key":"20_CR73","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1007\/s00415-003-0178-1","volume":"250","author":"M. Pohl","year":"2003","unstructured":"Pohl M, Rockstroh G, Ruckriem S, Mehrholz J, Pause M, Koch R, Strik H (2003) Time course of the effect of a bolus dose of intrathecal baclofen on severe cerebral spasticity. J Neurol 250(10): 1195\u20131200","journal-title":"J Neurol"},{"key":"20_CR74","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S0003-9993(02)04906-7","volume":"84","author":"O. Remy-Neris","year":"2003","unstructured":"Remy-Neris O, Tiffreau V, Bouilland S, Bussel B (2003) Intrathecal baclofen in subjects with spastic hemiplegia: assessment of the antispastic effect during gait. Arch Phys Med Rehabil 84: 643\u2013650","journal-title":"Arch Phys Med Rehabil"},{"key":"20_CR75","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/j.2048-7940.2006.tb00381.x","volume":"31","author":"B. Ridley","year":"2006","unstructured":"Ridley B (2006) Intrathecal baclofen therapy: challenges in patients with multiple sclerosis. Rehabil Nurs 31: 158\u2013164","journal-title":"Rehabil Nurs"},{"key":"20_CR76","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0006-8993(75)90928-2","volume":"97","author":"K. Saitoh","year":"1975","unstructured":"Saitoh K, Konish S, Otsuka M (1975) Antagonism between lioresal and substance P in rat spinal cord. Brain Res 97: 177\u2013180","journal-title":"Brain Res"},{"key":"20_CR77","first-page":"271","volume":"49","author":"B. Sallerin","year":"2003","unstructured":"Sallerin B, Lazorthes Y (2003) Intrathecal baclofen. Experimental and pharmacokinetic studies. Neurochirurgie 49: 271\u2013275","journal-title":"Neurochirurgie"},{"key":"20_CR78","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/0006-8993(86)90171-X","volume":"386","author":"J. Sawynok","year":"1986","unstructured":"Sawynok J, Reid A (1986) Role of ascending and descending noradrenergic pathways in the antinociceptive effect of baclofen and clonidine. Brain Res 386: 341\u2013350","journal-title":"Brain Res"},{"key":"20_CR79","unstructured":"Shakespeare DT, Boggild M, Young C (2001) Anti-spasticity agents for multiple sclerosis. Cocbrane Databse Syst Rev, CD001332"},{"key":"20_CR80","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1212\/WNL.45.10.1893","volume":"45","author":"P.L. Silbert","year":"1995","unstructured":"Silbert PL, Matsumoto JY, McManis PG, Stolp-Smith KA, Elliott BA, McEvoy KM (1995) Intrathecal baclofen therapy in stiff-man syndrome: a double-blind, placebo-controlled trial. Neurology 45: 1893\u20131897","journal-title":"Neurology"},{"key":"20_CR81","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0378-5173(97)04926-0","volume":"153","author":"B.R. Sitaram","year":"1997","unstructured":"Sitaram BR, Tsui M, Rawicki HB, Sitaram M (1997) Stability and compatibility of intrathecal admixtures containing baclofen and high concentrations of morphine. Int J Pharmaceutics 153: 13\u201324","journal-title":"Int J Pharmaceutics"},{"key":"20_CR82","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.rapm.2004.01.005","volume":"29","author":"M. Slonimski","year":"2004","unstructured":"Slonimski M, Abram SE, Zuniga RE (2004) Intrathecal baclofen in pain management. Reg Anesth Pain Med 29: 269\u2013276","journal-title":"Reg Anesth Pain Med"},{"key":"20_CR83","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1002\/mds.20405","volume":"20","author":"D.B. Smail","year":"2005","unstructured":"Smail DB, Jacq C, Denys P, Bussel B (2005) Intrathecal baclofen int eh treatment of painful, disabling spasms in Friedreich\u2019s ataxia. Mov Disord 20: 758\u2013759","journal-title":"Mov Disord"},{"key":"20_CR84","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1097\/00002060-200011000-00010","volume":"79","author":"L. Stempien","year":"2000","unstructured":"Stempien L, Tsai T (2000) Intrathecal baclofen pump use for spasticity. Am J Phys Med Rehabil 79: 536\u2013541","journal-title":"Am J Phys Med Rehabil"},{"key":"20_CR85","doi-asserted-by":"crossref","unstructured":"Taira T, Hori T (2006) Intrathecal baclofen in the treatment of post-stroke central pain, dystonia, and persistent vegetative state. Acta Neurochir Suppl (in press)","DOI":"10.1007\/978-3-211-33079-1_31"},{"key":"20_CR86","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1159\/000098905","volume":"65","author":"T. Taira","year":"1995","unstructured":"Taira T, Kawamura H, Tanikawa T, Iseki H, Kawabatake H, Takakura K (1995) A new approach to control central deafferentiation pain: Spinal intrathecal baclofen. Stereotactic Funct Neurosurg 65: 101\u2013105","journal-title":"Stereotactic Funct Neurosurg"},{"key":"20_CR87","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1111\/j.1440-1681.1995.tb02966.x","volume":"22","author":"K. Takenaka","year":"1995","unstructured":"Takenaka K, Sasaki S, Nakamura K, Uchida A, Fujita H, Itoh H, Nakata T, Takeda K, Nakagawa M (1995) Hypothalamic and medullary GABAA and GABAB-ergic systems differently regulate sympathetic and cardiovascular systems. Clin Exp Pharmacol Physiol Suppl 22: S48\u2013S50","journal-title":"Clin Exp Pharmacol Physiol Suppl"},{"key":"20_CR88","first-page":"258","volume":"22","author":"M. Tsui","year":"1992","unstructured":"Tsui M, Lam S (1992) Stability of intrathecal baclofen and morphine (Letter). Aust J Hosp Pharm 22: 258","journal-title":"Aust J Hosp Pharm"},{"key":"20_CR89","first-page":"81","volume":"87","author":"M.S. Turner","year":"2003","unstructured":"Turner MS (2003) Early use of intrathecal baclofen in brain injury in pediatric patients. Acta Neurochir Suppl 87: 81\u201383","journal-title":"Acta Neurochir Suppl"},{"key":"20_CR90","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1056\/NEJM200008313430905","volume":"343","author":"B.J. Hilten van","year":"2000","unstructured":"van Hilten BJ, van de Beek WJ, Ho JI, Voormolen JH, Delhaas EM (2000) Intrathecal baclofen for the treatment of dystonia in patients with reflex sympathetic dystrophy. N Engl J Med 343: 625\u2013630","journal-title":"N Engl J Med"},{"key":"20_CR91","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s11940-003-0024-x","volume":"5","author":"O.M. Vasconcelos","year":"2003","unstructured":"Vasconcelos OM, Dalakas MC (2003) Stiff-person syndrome. Curr Treat Options Neurol 5: 79\u201390","journal-title":"Curr Treat Options Neurol"},{"key":"20_CR92","first-page":"207","volume":"2","author":"J.J. Vatine","year":"1989","unstructured":"Vatine JJ, Magora F, Swissa A, Magora A (1989) Effect of intrathecal baclofen in low back pain with root compression symptoms. Pain Clin 2: 207\u2013217","journal-title":"Pain Clin"},{"key":"20_CR93","first-page":"11","volume":"2","author":"M. Vloeberghs","year":"2002","unstructured":"Vloeberghs M (2002) Intrathecal baclofen in the management of spasticity due to cerebral palsy. Adv Clin Neurosci Rehabil 2: 11\u201313","journal-title":"Adv Clin Neurosci Rehabil"},{"key":"20_CR94","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1002\/1531-8257(200011)15:6<1242::AID-MDS1028>3.0.CO;2-Z","volume":"15","author":"R.H. Walker","year":"2000","unstructured":"Walker RH, Danisi FO, Swope DM, Goodman RR, Germano IM, Brin MF (2000) Intrathecal baclofen for dystonia: benefits and complications during six years of experience. Mov Disord 15: 1242\u20131247","journal-title":"Mov Disord"},{"key":"20_CR95","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/0014-2999(78)90423-5","volume":"51","author":"P. Wilson","year":"1978","unstructured":"Wilson P, Yaksh TL (1978) Baclofen is antinociceptive in the spinal intrathecal space of animals. Eur J Pharmacology 51: 323\u2013320","journal-title":"Eur J Pharmacology"},{"key":"20_CR96","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1136\/jnnp.2003.014282","volume":"75","author":"A. Zahavi","year":"2004","unstructured":"Zahavi A, Geertzen JH, Middel B, Staal M, Rietman JS (2004) Long term effect (more than five years) of intrathecal baclofen on impairment, disability, and quality of life in patients with severe spasticity of spinal origin. J Neurol Neurosurg Psychiatry 75: 1553\u20131557","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"20_CR97","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1126\/science.8380942","volume":"259","author":"S.J. Zhang","year":"1993","unstructured":"Zhang SJ, Jackson MB (1993) GABA-activated chloride channels in secretory nerve endings. Science 259: 531\u2013534","journal-title":"Science"},{"key":"20_CR98","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1097\/00000542-200003000-00037","volume":"92","author":"R.E. Zuniga","year":"2000","unstructured":"Zuniga RE, Schlicht CR, Abram SE (2000) Intrathecal baclofen is analgesic in patients with chronic pain. Anesthesiology 92: 876\u2013880","journal-title":"Anesthesiology"},{"key":"20_CR99","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1053\/rapm.2002.29244","volume":"27","author":"R.E. Zuniga","year":"2002","unstructured":"Zuniga RE, Perera S, Abram SE (2002) Intrathecal baclofen; a useful agent in the treatment of well-established complex regional pain syndrome. Reg Anesth Pain Med 27: 90\u201393","journal-title":"Reg Anesth Pain Med"}],"container-title":["Acta Neurochirurgica Supplements","Operative Neuromodulation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-211-33079-1_20.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T11:21:29Z","timestamp":1607599289000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-211-33079-1_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[null]]},"ISBN":["9783211330784"],"references-count":99,"URL":"https:\/\/doi.org\/10.1007\/978-3-211-33079-1_20","relation":{},"subject":[]}}